BioSig Technologies Shares Surge 10.18% on Key Appointments

BioSig Technologies, Inc. (Nasdaq: BSGM) shares surged 10.18% in pre-market trading on June 11, 2025, driven by strategic advancements and key appointments.

BioSig Technologies, Inc. recently appointed Trevor Bacon and Kellan Grenier, co-founders of Parcl, as strategic advisors. This move is expected to enhance BioSig's capabilities in decentralized finance and real-world asset tokenization. Parcl, a leading blockchain-native platform, enables users to gain exposure to real estate markets through synthetic, perpetual trading. Under Trevor and Kellan’s leadership, Parcl has become one of the most advanced protocols focused on bridging real estate and decentralized finance.

Trevor Bacon, CEO and Co-Founder of Parcl, brings over a decade of experience in finance, including roles at Barclays and several hedge funds. Kellan Grenier, Co-Founder and COO of Parcl, has extensive experience as a long/short equity analyst in the TMT sector and has been deeply involved in blockchain technology for over five years. Their expertise is expected to be instrumental in scaling BioSig and Streamex’s infrastructure for tokenizing and trading real-world assets, particularly in illiquid and fragmented markets.

Henry McPhie, CEO of BioSig and Co-Founder of Streamex, expressed enthusiasm about the appointments, stating that Trevor and Kellan’s experience in building one of the most forward-thinking decentralized trading platforms makes them an ideal fit for BioSig and Streamex’s mission. The advisory team now includes distinguished figures such as Frank Giustra, Sean Roosen, and Mathew August, each bringing world-class experience to the company’s mission of transforming global commodity markets through tokenization.